AbCellera Biologics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | $11.6M | — |
| Dec 2019 | — | $10.3M | — |
| Mar 2020 | — | $83.7M | — |
| Jun 2020 | — | $90.9M | — |
| Sep 2020 | — | $89.3M | — |
| Dec 2020 | — | $830.5M | $594.1M |
| Mar 2021 | — | $957.1M | $685.8M |
| Jun 2021 | — | $967.7M | $792.6M |
| Sep 2021 | — | $953.4M | $517.7M |
| Dec 2021 | — | $1.03B | $476.1M |
| Mar 2022 | — | $1.21B | $545.7M |
| Jun 2022 | — | $1.21B | $790.6M |
| Sep 2022 | — | $1.25B | $372.0M |
| Dec 2022 | — | $1.23B | $386.5M |
| Mar 2023 | — | $1.21B | $193.0M |
| Jun 2023 | — | $1.19B | $179.7M |
| Sep 2023 | — | $1.18B | $172.4M |
| Dec 2023 | — | $1.15B | $133.3M |
| Mar 2024 | — | $1.13B | $123.6M |
| Jun 2024 | — | $1.11B | $148.3M |
| Sep 2024 | — | $1.08B | $126.6M |
| Dec 2024 | — | $1.06B | $156.3M |
| Mar 2025 | — | $1.02B | $159.3M |
| Jun 2025 | — | $1.01B | $92.4M |
| Sep 2025 | — | $964.0M | $83.2M |
| Dec 2025 | — | $966.9M | $128.5M |
| Mar 2026 | — | $938.1M | $77.1M |
| Jun 2026 | — | $896.0M | $120.1M |